K Pharma was founded in November 2016 as a venture company originating from the Keio University School of Medicine. The Company was established to commercialize the results of many years of basic research led by Hideyuki Okano, Professor of Physiology, and Masaya Nakamura, Professor of Orthopaedic Surgery, both at the Keio University School of Medicine, with the goal of delivering effective treatments for neurological diseases with no established effective therapies to patients as quickly as possible. For more information, please refer to the History section.
On which stock exchange is K Pharma listed?
K Pharma was listed on the Tokyo Stock Exchange Growth Market on October 17, 2023.
What is K Pharma's securities code?
The Company's securities code is 4896.
When does K Pharma announce its financial results?
The Company's fiscal year ends on December 31, and its full-year financial results are generally announced in February. For the schedule of quarterly financial results announcements, please refer to the IR Calendar.
Where can I find K Pharma's past financial results?
The record date for year-end dividends is December 31. If an interim dividend is declared, the record date will be June 30.
What is the share trading unit?
The share trading unit is 100 shares. * A share trading unit refers to the minimum number of shares that can be traded on the stock exchange.
How can I change my registered shareholder information, such as my name or address?
For procedures related to your shareholdings, including changes to your registered name or address, please contact the securities company where you maintain your brokerage account.
When is the Annual General Meeting of Shareholders held?
The Annual General Meeting of Shareholders is generally held in late March each year. Shareholders of record as of December 31 will receive a notice of convocation in early March, including the date, time, and venue of the meeting.
How can I exercise my voting rights at the Annual General Meeting of Shareholders?
Shareholders recorded in the shareholder register as of the applicable record date (December 31 for the Annual General Meeting of Shareholders) will receive a notice of convocation together with a voting form. Voting rights may be exercised by one of the following methods:
Attending the meeting in person and submitting the voting form.
Indicating your vote on the voting form and returning it by mail.
Accessing the designated voting website and submitting your vote online.
Who should I contact to request IR materials or make other inquiries?
